Natriuretic peptides, namely, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) as well as their cleaved by-products MRproANP and NTproBNP, belong to the most widely studied blood biomarkers to distinguish CE from non-CE stroke. This evidence concerns the gene NPPB and cholesteryl ester measurement.